ANIK Anika Therapeutics, Inc.
Healthcare$14.89+0.07%ClosedMarket Cap: $198.1M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+12,200
Shares Acquired
12,200
Shares Disposed
0
Total Bought ($)
$1.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon May 04 | HENNEMAN JOHN B III | director | Buy | 5,000 | $14.66 | 54,871 |
| Thu Apr 30 | Griffin Stephen D. | director, officer: President and CEO | Buy | 12,200 | $12.29 | 36,163 |
| Mon Mar 23 | McLeod Ian | officer: SVP, CAO & Treasurer | Sell | 17,663 | $15.60 | 17,663 |
| Mon Mar 23 | McLeod Ian | officer: SVP, CAO & Treasurer | Sell | 13,097 | $0.00 | 13,097 |
| Mon Mar 23 | McLeod Ian | officer: SVP, CAO & Treasurer | Sell | 11,194 | $0.00 | 11,194 |
| Tue Mar 17 | Colleran David | officer: EVP, General Counsel, Corp Sec | Sell | 9,388 | $0.00 | 62,488 |
| Tue Mar 17 | Colleran David | officer: EVP, General Counsel, Corp Sec | Sell | 6,449 | $0.00 | 69,463 |
| Tue Mar 17 | Colleran David | officer: EVP, General Counsel, Corp Sec | Sell | 4,168 | $14.20 | 63,014 |
| Tue Mar 17 | Colleran David | officer: EVP, General Counsel, Corp Sec | Sell | 1,893 | $14.20 | 67,570 |
| Tue Mar 17 | Colleran David | officer: EVP, General Counsel, Corp Sec | Sell | 4,694 | $0.00 | 67,182 |